Generic Name: empagliflozin/linagliptin

Pill with imprint 10/5 Logo is Yellow, Three-sided and has been identified as Glyxambi empagliflozin 10 mg / linagliptin 5 mg. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Glyxambi is used in the treatment of Diabetes, Type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glyxambi empagliflozin 10 mg / linagliptin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).